Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock $0.001 par value per share
-
Shares outstanding
-
77.8M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
+14.8M
-
Total reported value, excl. options
-
$80.8M
-
Value change
-
+$79.6M
-
Number of buys
-
28
-
Price
-
$5.38
Significant Holders of Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) as of Q4 2022
31 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share as of Q4 2022.
Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 77.8M outstanding shares and own 19.29% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.5M shares), RA CAPITAL MANAGEMENT, L.P. (3.43M shares), Bain Capital Life Sciences Investors, LLC (3.13M shares), Camber Capital Management LP (1.42M shares), Laurion Capital Management LP (928K shares), Artal Group S.A. (909K shares), Alyeska Investment Group, L.P. (540K shares), K2 PRINCIPAL FUND, L.P. (342K shares), VANGUARD GROUP INC (223K shares), and Finepoint Capital LP (219K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.